Catalog Products » GMP GenCRISPR™ NLS-wtSpCas9, his-tag
GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 1. Cas9 cuts substrate DNA standard via in vitro cutting experiment. Results show the cleavage activity of GenScript Cas9 is equivalent to that of leading competitors.

GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 2. The purity of GenScript Cas9 detected by SEC-HPLC is greater than 95%.

GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 3. The purity of Cas9 Nuclease detected by RP-HPLC was higher than 95%

GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 4. In vitro cleavage assays showed that the in vitro cleavage activity of Cas9 Nuclease was consistent across three batches, which are all higher than 85%

GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 5. Cas9 is electrotransfected into 293T cell line in the form of RNP to knock out the target gene. Results show GenScript Cas9 has the same knockout efficiency as leading competitors.

GMP GenCRISPR™ NLS-wtSpCas9, His-tag

Figure 6. Cas9 Nuclease is used for gene knockout in 293T and Jurkat cell lines. As shown in the figure, the gene knockout efficiency of the three batches of Kactus Cas9 Nuclease is comparable.

GMP GenCRISPR™ NLS-wtSpCas9, his-tag

This newly wtSpCas9 is produced by expression in an E. coli strain carrying a plasmid encoding the Cas9 gene from Streptococcus pyogenes with an nuclear localization signal (NLS) and his-tag.
RC00002
$8000.00

Ask us a question
Description

CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and Cas9.

Applications
Genome editing with CRISPR T-Cells, Stem Cells, etc.

Quality Control Specifications
Appearance Clear liquid
Purity ≥ 95.0% by RP-HPLC, Monomer ≥ 95.0%, Aggregates ≤ 5.0% by SEC-HPLC, ≥ 85.0% by NR-CE, ≥ 90.0% by R-CE
Quality GMP-Grade, Suitable for Manufacturing, Antibiotic-free and animal-free production
Concentration 9.5-11.5 mg/mL
Bioactivity cleavage activity>85%
Residual DNase Negative
Residual RNase Negative
Endotoxin Level ≤ 10.0EU/mg
Residual HCP ≤ 100.0 ng/mL
Residual HCD ≤ 3.0 ng/mL
Sterility No growth
Residual Nickel Salt ≤ 10.0 ppm
pH 7.4±0.5

Properties
Synonyms CRISPR-associated endonuclease Cas9/Csn1, cas9, SpCas9, SpyCas9
Source This product has undergone codon optimization, nuclear localization signal (NLS) design, and optimization of E. coli expression and purification.
Species Streptococcus pyogenes
Tag His tag
Molecular Weight 163 kDa
Concentration 10 mg/ml
Active temperature This Cas9 is active at 37°C.
Formulation Supplied as a solution of 30mM Tris-HCl, 0.3M NaCl, 50% Glycerol, 0.1 mM EDTA, pH 7.4
Storage & Stability This product remains stable for up to 18 months at -20±5°C. Avoid repeated freeze-thaw cycles.

Examples
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 1. Cas9 cuts substrate DNA standard via in vitro cutting experiment. Results show the cleavage activity of GenScript Cas9 is equivalent to that of leading competitors.

  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 2. The purity of GenScript Cas9 detected by SEC-HPLC is greater than 95%.

  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 3. The purity of Cas9 Nuclease detected by RP-HPLC was higher than 95%

  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 4. In vitro cleavage assays showed that the in vitro cleavage activity of Cas9 Nuclease was consistent across three batches, which are all higher than 85%

  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 5. Cas9 is electrotransfected into 293T cell line in the form of RNP to knock out the target gene. Results show GenScript Cas9 has the same knockout efficiency as leading competitors.

  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag
  • GMP GenCRISPR™ NLS-wtSpCas9, His-tag

    Figure 6. Cas9 Nuclease is used for gene knockout in 293T and Jurkat cell lines. As shown in the figure, the gene knockout efficiency of the three batches of Kactus Cas9 Nuclease is comparable.